The Centers for Medicare and Medicaid Services has released the names of 10 drugs that will be subject to federal price negotiation in the Medicare program.
The selected drug list for the first round of negotiation is:
Eliquis, Jardiance and Xarelto lead CMS list of drugs subject to negotiation
